Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

NRIX — Nurix Therapeutics, Inc. Dilution Risk Tracker

Track NRIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NRIX — Get alerts when the score changes →

As of October 13, 2026, Nurix Therapeutics, Inc. (NRIX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Nurix Therapeutics, Inc. has a market capitalization of $2.30B, 103.78M shares outstanding, 198 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $413.65M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $414M remaining capacity
🔔 Track NRIX — Get forecast alerts →

Market Data

Market Cap$2.30B
Shares Outstanding103.78M
Float82.40M
Cash$312.35M
Debt$58.66M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding103.78MVerified float table or market cache
Public Float82.40MVerified float table or market cache
Market Cap$2.30BMarket data cache
Cash Runway16.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$413.65MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 18.4% shares (2026Q1 vs prior)
198 institutional holders · 136.87M shares
#1 MORGAN STANLEY 12.07M shares
#2 BlackRock, Inc. 8.93M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 8.85M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.66M
Days to Cover9.9
% of Float21.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-01-28
xbrl XBRL CONVERTIBLE 2022-01-28
4 INSIDER TRANSACTION 2026-04-02
8-K 8K EVENT 2026-03-06
424B5 ATM 2026-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NRIX Dilution Snapshot

Nurix Therapeutics, Inc. (NRIX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NRIX's DilutionScore is currently 35/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 42/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202635/100MEDIUM4 days
Jul 16 – Oct 09, 202642/100MEDIUM85 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NRIX shares outstanding have decreased 0.0% from 103.41M (Mar 2026) to 103.41M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 2026103.41M82.40M▼ 6.58%
May 09, 2026103.41M88.21M▲ 0.02%
May 04, 2026103.41M88.19M▼ 0.01%
May 01, 2026103.41M88.20M▼ 7.38%
Apr 28, 2026103.41M95.23M▲ 9.29%
Apr 09, 2026103.41M87.14M▲ 0.55%
Mar 30, 2026103.41M86.65M▲ 0.10%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NRIX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NRIX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NRIX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NRIX
NRIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.